LEI 9676001DY9Y4S829IN54

EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI

Awards tracked

17

Value

€24.09M

Countries

BE

Download sample CSV

Contract awards & public grants

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2023-04-24

€129,125

INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2023-04-21

€6.27M

Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2023-04-21

€4.49M

A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER A

European Commission · BE · Grant · 2023-04-21

€4.11M

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2022-12-02

€583,000

Providing cutting edge cancer research services across Europe → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2022-07-14

€638,895

THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2022-05-20

€400,300

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2021-10-18

€3,000

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER A

European Commission · BE · Grant · 2020-11-09

€247,120

Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2020-05-18

€300,000

Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2019-04-23

€5.26M

European Joint Programme on Rare Diseases → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2018-12-13

€5,150

Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement fo → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCE

European Commission · BE · Grant · 2018-12-03

€862,250

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2018-06-14

€16,000

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2017-03-10

€414,480

Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER AISBL

European Commission · BE · Grant · 2016-12-22

€30,203

Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriCol → ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCE

European Commission · BE · Grant · 2015-04-16

€331,000

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.